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Vitamin B-6 is important for skin development and
maintenance. We examined vitamin B-6 metabolism
in human and mouse skin collected at di¡erent phases
of the hair cycle; in hamster melanomas; in normal
and immortalized human keratinocytes (HaCaT) and
several human melanoma cell lines. Pyridoxamine
50 -phosphate content was higher in mouse and hamster
than in human skin. Activity of both pyridoxamine
50 -phosphate oxidase and pyridoxal 50 -phosphate hy-
drolase was signi¢cantly increased in rapidly growing
melanomas compared to either normal skin or slower
growing skin tumors. Reducing the pyridoxine content
of the culture medium signi¢cantly increased the activ-
ity of pyridoxal kinase and pyridoxamine 50 -phosphate
oxidase. Pyridoxal 50 -phosphate hydrolase has been
proposed as a regulatory enzyme for vitamin B-6,
but we found B-6 vitamer content to be signi¢cantly
correlated only with kinase and oxidase activity and
not with pyridoxal 50 -phosphate hydrolase activity.
Although pyridoxal 50 -phosphate hydrolase activity is
usually attributed to tissue-nonspeci¢c alkaline phos-
phatase, tissue-nonspeci¢c alkaline phosphatase knock-
out mice showed preservation of normal histology of
the skin and adnexal structures. Furthermore, expres-
sion of tissue-nonspeci¢c alkaline phosphatase mRNA
was not detected in either HaCaT cells or human skin,
both of which exhibited signi¢cant pyridoxal 50 -phos-
phate hydrolase activity. This suggests that an enzyme
di¡erent from the classical tissue-nonspeci¢c alkaline
phosphatase may perform cutaneous pyridoxal 50 -phos-
phate hydrolase activity. Key words: alkaline phosphatase/
mammalian skin/melanoma/vitamin B6. J Invest Dermatol
120:292 ^300, 2003
V
itamin B-6 is an important nutrient that serves as a
cofactor for at least 110 enzymes (Nomenclature
Committee of the International Union of Biochem-
istry, 1992). Its chemistry and metabolism have re-
cently been reviewed (McCormick, 2001). Brie£y,
vitamin B-6 occurs in three free forms: pyridoxal (PL), pyridox-
amine (PM), and pyridoxine (PN), which can be phosphorylated
to the corresponding 50 -phosphates. Pyridoxal 50 -phosphate
(PLP) serves as a coenzyme in reactions involving catabolism of
various amino acids and decarboxylation reactions necessary for
generation of the neurotransmitters dopamine, serotonin, hista-
mine, g-aminobutyric acid, and taurine. PLP as the cofactor of
ornithine decarboxylase regulates polyamine synthesis, thereby
a¡ecting phospholipid, nucleic acid, and protein synthesis.
Through its participation in methionine metabolism vitamin B-
6 in£uences the metabolism of phosphatidyl choline and (n^3)
polyunsaturated fatty acids (Tsuge et al, 2000) as well as homocys-
teine (McCormick, 2001). PLP also a¡ects expression and action
of steroid hormone receptors (Tully et al, 1994) and modi¢es im-
mune function through actions onTand B lymphocyte responses
(Rall and Meydani, 1993). About 70% of the vitamin B-6 in the
body is located in muscle (Coburn et al, 1988) where it is primar-
ily associated with glycogen phosphorylase.
The phosphorylation of PL, PM, and PN is catalyzed by PL
kinase. PLP and pyridoxamine 50 -phosphate (PMP) are intercon-
vertible through aminotransferases or PMP/pyridoxine 50 -phos-
phate (PNP) oxidase. Removal of the phosphate group is a
function of alkaline phosphatases, which are encoded by at least
four di¡erent genes producing tissue-nonspeci¢c (TNAP), intest-
inal, placental, and germ cell enzymes (Van Hoof and De Broe,
1994). The alkaline phosphatase involved predominantly in vita-
min B-6 metabolism is the TNAP isozyme (Whyte, 1995). It is
anchored to the ectoplasmic side of the plasma membrane by gly-
cosylphosphatidylinositol. As only dephosphorylated vitamers
can be transported into the cells, decreased activity of TNAP
results in marked increases in plasma PLP (Whyte et al, 1985).
Symmetrical, pellagra-like dermatitis was the earliest recog-
nized symptom of vitamin B-6 de¢ciency (Gy˛rgy, 1934)
although initial indications that PN therapy was bene¢cial in
atopic dermatitis (Koller et al, 1992) were not con¢rmed in a sub-
sequent study (Mabin et al, 1995). Excessive exposure to vitamin
B-6 can cause dermatitis (Yoshikawa et al, 1985; Friedman et al,
1986; Camarasa et al, 1990) and increased photosensitivity in hu-
mans (Morimoto et al, 1996; Murata et al, 1998; Bajaj et al, 2001)
and in cell cultures (Sato et al, 1993). In contrast to these photo-
toxic e¡ects, vitamin B-6 may protect against photosensitivity
in some microorganisms (Osmani et al, 1999). Vitamin B-6 sup-
plements inhibit the growth of melanomas in vivo and in vitro
(Maksymowych et al, 1993).
To clarify the actions of vitamin B-6 in the skin, we exa-
mined the cutaneous expression of PL kinase, PMP oxidase,
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PLP hydrolase, and the concentrations of B-6 vitamers under
various experimental conditions.
MATERIALS AND METHODS
Tissues Fresh human skin was obtained from tissue removed during
surgery. Skin was frozen quickly in liquid nitrogen and stored at ^801C
until the time of analysis. The use of human tissues was approved by the
University of Tennessee Health Science Center Committee on Research
Involving Human Subjects (protocol: skin as neuroendocrine organ).
Mice C57BL/6 strain female (8-wk-old) and Syrian hamsters (males 3-
mo-old) were purchased from Taconic (NY) and housed in community
cages at the animal facilities of the Albany Medical College, Albany, NY.
The animals were sacri¢ced under pentobarbital anesthesia and selected
organs as well as back skin were collected following protocols routinely
used in our laboratory (Slominski et al, 1991; 1996). Tissue specimens were
frozen rapidly in liquid nitrogen. Hamster Bomirski Ma melanotic, MI
hypomelanotic, and Ab amelanotic melanomas (see Table I) were
propagated in male Syrian hamsters by subcutaneous inoculation of tissue
suspension as described previously (Bomirski et al, 1988). After
euthanization the tumor tissue was freed from connective and necrotic
tissues and frozen rapidly in liquid nitrogen (Bomirski et al, 1988). Murine
and hamster tissues as well as melanoma transplants were stored at ^801C
until further analysis. The experimental protocols were approved by the
appropriate Institutional Animal Care and Use Committees.
Cells Characteristics of cell lines used for experiments are provided in
Table I. Human keratinocytes (HaCaT) were propagated in Dulbecco’s
modi¢ed Eagle’s medium (DMEM), whereas human melanoma (SK-
MEL188), hamster melanoma (Bomirski AbC-1) and mouse Cloudman
S91 melanoma (subline #6) cells were grown in Ham’s F10 medium as
described previously (Slominski et al, 1988). The media were supplemented
with 10% fetal bovine serum (FBS) and antibiotics (Slominski et al, 1992;
1998; 1999a; 1999b). Human melanoma cells including lines established
from radial growth phase (WM 35), vertical growth phase (WM 98), and
metastatic (WM 852 and WM 164) melanomas were cultured in DMEM
supplemented with 10% FBS, insulin (5 mg per ml), and antibiotics (Hsu
et al, 1999). Normal human neonatal keratinocytes from passages 2 and 3
were used for experiments (Quevedo et al, 2001). Primary cell cultures
were established from foreskin as described previously (Quevedo et al,
2001). The cells were propagated in low-calcium (0.15 mM) serum-free
keratinocyte growth medium (KGM) containing bovine pituitary extract
(BPE) and antibiotics (Clonetics, San Diego, CA). Squamous cell
carcinoma (C1-4) was cultured in Ham’s F10 plus 10% FBS (Slominski
et al, 1998). After washing with phosphate-bu¡ered saline melanoma cells
were detached with Tyrode’s solution containing 1 mM ethylenediamine
tetraacetic acid (Slominski et al, 1988; 1999a), whereas normal and
malignant keratinocytes were trypsinized (Slominski et al, 1998; 1999a;
Quevedo et al, 2001). The cells were centrifuged at 41C and washed with
cold phosphate-bu¡ered saline; cell pellets were frozen at ^801C until
further analysis.
Tissue and cell extract preparations Cell pellets were thawed and
diluted with water to approximately 106 cells per ml, mixed, and frozen.
Tissue homogenates (50^100 mg tissue per ml of water) were prepared
using a Virtis Model 60K homogenizer. The homogenates were frozen
and centrifuged or ¢ltered before use. Protein was determined according
to Lowry et al (1951) using bovine albumin as a standard.
Assays for enzymatic activities and B-6 vitamers PLP hydrolase, PL
kinase (EC 2.7.1.35), and PMP oxidase (EC 1.4.3.5) activities were
determined with modi¢cations of the method developed for B-6
metabolic enzymes by Ubbink and Schnell (1988). Hydrolysis of PLP or
PNP was measured at pH 10 in 0.1 M Tris bu¡er containing 0.05 M
magnesium chloride. PL kinase activity was measured at pH 6 in 0.1 M
potassium phosphate bu¡er containing 2 mM magnesium chloride, 0.2
mM zinc chloride, and 2 mM ATP. PMP oxidase activity was measured
at pH 10 in 0.2 M Tris bu¡er containing 0.1 M sodium phosphate and
0.003 mM £avin mononucleotide. Enzyme activities were expressed in
pmols of product per mg protein per min. B-6 vitamers were determined
by cation exchange high performance liquid chromatography (Mahuren
and Coburn, 1990).
Statistical analyses were performed using analysis of variance (SigmaStat,
Jandel). The di¡erences were considered signi¢cant for po0.05. The values
are presented as means7SD.
Northern blot analysis Total RNAwas isolated from skin and cultured
cells using the TRIsol kit following the manufacturer’s speci¢cations
(Slominski et al, 1998; 1999a). Ten micrograms of total RNA per lane was
separated on 1% agarose and transferred to nylon membranes. 32P-labeled
1.1 kb Sma I fragment of the mouse TNAP cDNA was used for
hybridization as described previously (Narisawa et al, 1994).
TNAP knockout mice The generation of a mouse line carrying a
targeted disruption of the TNAP gene has been described previously
(Narisawa et al, 1997). Ten-day-old pups from the TNAP knockout mouse
strain were euthanized using CO2 gas. Skin patches from TNAP ^/^ and
littermate control mice were ¢xed in bu¡ered formalin and processed into
para⁄n blocks using standard histology protocols. Sections were stained
with hematoxylin and eosin before observation. The TNAP genotypes of
the sacri¢ced mice were determined as before (Narisawa et al, 1997).
RESULTS
Vitamin B-6 metabolism in normal skin Total B-6 vitamer
concentrations in skin were not signi¢cantly di¡erent between
species (Table II), but PMP was lower in humans than in mouse
and hamster.Whereas the activities of PL kinase and PLP hydro-
lase were similar in skin samples from di¡erent species, PMP
oxidase activity tended to be higher in mouse skin (Table III).
The kinase/oxidase ratio was signi¢cantly increased in hamster
skin due to the low oxidase activity. Because the physiology and
morphology of the rodent skin changes during hair growth, we
Table I. Description of cell lines
Source Characteristics Culture medium
Human
SK-MEL188 melanoma Hypomelanotic line Ham’s F10þ10% FBS
WM 35 melanoma Amelanotic line that derives from radial growth phase DMEMþ10% FBS
WM 164 melanoma Amelanotic line that derives from metastasis DMEMþ10% FBS
WM 98 melanoma Amelanotic line that derives from vertical growth phase DMEMþ10% FBS
WM 852 melanoma Amelanotic line that derives from metastasis DMEMþ10% FBS
HaCaT keratinocytes Immortalized epidermal keratinocytes DMEMþ10% FBS
C1-4 line Squamous cell carcinoma Ham’s F10þ10% FBS
Foreskin Neonatal keratinocytes KGM plus BPE
Hamster
Bomirski Ma melanoma Melanotic tumor transplantable in hamsters N/A
Bomirski MI melanoma Hypomelanotic tumor transplantable in hamsters N/A
Bomirski Ab melanoma Amelanotic tumor transplantable in hamsters N/A
Bomirski AbC-1 line Established in vitro cell line from Ab tumor Ham’s F10þ10% FBS
Mouse
S91 melanoma (#6) Amelanotic clone of Cloudman S91 melanoma Ham’s F10þ10% FBS
N/A, the tumors were propagated in vivo by subcutaneous transplantation.
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tested the skin of the C57BL/6 mouse model at di¡erent phases of
the hair cycle: telogen (resting phase) and anagen II, IV, and VI
(growing phase of the hair cycle) (Muller-Rover et al, 2001).
There were no signi¢cant di¡erences between the concentrations
of B-6 vitamers (Table II) or activities of the kinase or oxidase
(Table III) at di¡erent stages of the hair cycle. There was a
tendency for the PLP hydrolase activity to increase during
progression of the hair cycle from telogen to anagen phases IV
and VI, however. B-6 vitamer content and enzyme activity in
skin were generally similar to other organs tested with the
exception of higher oxidase activity in liver and higher PLP
hydrolase activity in kidney.
To characterize the molecular nature of PLP dephosphory-
lation activity we performed northern blot hybridization of
RNA isolated from human and rodent tissues with a TNAP
cDNA probe. This test showed a 2.4 kb mRNA transcript
corresponding to TNAP in mouse and hamster melanoma cells
and in anagen VI skin (Fig 1). Very low expression (only at the
limit of detectability) of the expected 2.4 kb TNAP transcript
was found in telogen and anagen II spleen and anagen II skin.
Gene expression was absent or below detectability in human
neonatal and HaCaT keratinocytes, and human skin biopsy.
Thus, the pattern of gene expression matched the changes in
enzyme activity in mouse tissues but not in human skin and
Table II. B-6 vitamers in skin and other organs
PLP PMP PL Total
Species Tissue (nmol per g protein) (nmol per g protein) (nmol per g protein) (nmol per g protein)
Human Skin 44713 (7)a 772 (7)b 29712 (6) 78714 (6)
Mouse Telogen:
Skin 35710 (4) 3176 (4)b, c 1372 (4) 7975 (4)
Anagen II:
Skin 52 (1) 4470 (2)b, c 1370 (2) 108 (1)
(po0.068)
Anagen IV:
Skin 75741 (2) 4474 (3)c 2779 (3) 146752 (2)
(po0.046)
Spleen 22 (1) 12 (1) 19 (1) 53 (1)
Liver 71 (1) 86 (1) 5 (1) 162 (1)
Kidney 26 (1) 78 (1) 3 (1) 107 (1)
AnagenVI:
Skin 57726 (3) 4778 (8)c 2479 (8) 150772 (3)
Spleen 42 (1) 30 (1) 95 (1) 167 (1)
Liver 93 (1) 162 (1) 21 (1) 276 (1)
Kidney 38 (1) 111 (1) 11 (1) 160 (1)
Hamster Skin 5871 (2) 4673 (2)c 1171 (2) 11572 (2)
Skin with nevus 34711 (2) 2076 (2)b, c 1373 (2) 67720 (2)
Brain 5771 (2) 10572 (2) 4073 (2) 20276 (2)
aMean7SEM. Number in parentheses is the number of samples. The variation in the number of samples between vitamers is due to the fact that some samples were
analyzed before we adapted the more sensitive chlorite technique. The totals reported represent only samples that gave results for all vitamers. Analysis of variance used
only skin data. Samples in the same column with di¡erent superscripts are signi¢cantly di¡erent (po0.05).
Table III. Activity of PL kinase, PMP oxidase, and PLP hydrolase in skin and other tissues
Kinase Oxidase PLPase
Species Tissue (nmol per g protein per min) (nmol per g protein per min) (nmol per g protein per min) Kinase/oxidase PLPase/kinase
Human Skin 1777 (7)a 4.170.9 (7)b 179752 (7) 3.871.2 (7)b 37715 (7)
Mouse Telogen:
Skin 2274 (4) 8.472.5 (3)b, c 241732 (4) 3.070.4 (3)b 1273 (4)
Anagen II:
Skin 2872 (2) 8.170.3 (2)b, c 222714 (2) 3.470.2 (2)b 8.070.2 (2)
Anagen IV:
Skin 4573 (3) 9.771.0 (3)b, c 482771 (3) 4.870.7 (3)b 1171 (3)
Spleen 23 (1) 11 (1) 212 (1) 2.2 (1) 9.1 (1)
Liver 26 (1) 35 (1) 27 (1) 0.7 (1) 1.0 (1)
Kidney 64 (1) 10 (1) 6300 (1) 6.7 (1) 97 (1)
AnagenVI:
Skin 3674 (8) 10.371.2 (7)c 534785 (8) 3.971.2 (7)b 1672 (8)
Spleen 44 (1) 15 (1) 489 (1) 2.9 (1) 11 (1)
Liver 33 (1) 39 (1) 47 (1) 0.9 (1) 1.4 (1)
Kidney 65 (1) 13 (1) 6316 (1) 5.2 (1) 97 (1)
Hamster Skin 2979 (2) 1.970.6 (2)b 161715 (2) 15.270.1 (2)c 6.472.6 (2)
Skin with nevus 1374 (2) 0.6570.05 (3)b 102726 (2) 20.777.3 (2)c 7.970.2 (2)
Brain 5971 (2) 1973 (2) 16872 (2) 3.370.9 (2) 2.970.3 (2)
aMean7SEM. Number in parentheses is the number of samples. Analysis of variance used only skin data.
Values with di¡erent superscripts in the same column are signi¢cantly di¡erent (po0.05).
The PLPase activity in anagenVI plus anagen IV (519763 (11)) is signi¢cantly higher (p¼ 0.005) than in telogen plus anagen II (235721 (6)).
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human keratinocytes (Table III). Therefore, PLPase activity in
mouse skin would correspond predominantly to TNAP.
Considering the high homology between human and mouse
TNAP, the lack of the detectable message in human skin
samples and particularly the HaCaT keratinocytes, which had
the highest PLPase activity of any cell line tested, suggest that
biochemically detectable cutaneous PLP alkaline phosphatase
activity may instead be coded by gene(s) other thanTNAP.
To clarify whether TNAP plays a role in skin morphogenesis
and hair follicle formation we examined histologic slides of the
skin of mice carrying a targeted disruption of the TNAP gene.
This experimental model mimics infantile hypophosphatasia in
humans. The hypophosphatasia mice have low viability and die
at 10^12 d of age unless supplemented with vitamin B-6
(Waymire et al, 1995). Skin biopsies obtained at days 7 and 9
after birth failed to show identi¢able pathology at the histologic
level with the exception of thinner skin in the knockout mice
(Fig 2). The epidermis, dermis, and number and structure of
hair follicles including banding pattern of hair shafts were
similar to controls. Thus, we conclude that TNAP does not play
a signi¢cant role in skin morphogenesis or formation of adnexal
structures.
Metabolism of vitamin B-6 in transplantable hamster
melanomas To evaluate the e¡ect of skin pathology on
vitamin B-6 metabolism we tested a family of hamster
Bomirski transplantable melanomas, linked by a common origin
but di¡ering in growth rate, di¡erentiation level, metabolic
activity, and immunogenicity (Bomirski et al, 1988; Slominski
and Paus, 1993a). Speci¢cally, the Ab amelanotic melanoma is
characterized by rapid growth rate, amelanotic (undi¡erentiated)
phenotype, and moderate metastasizing capacity (48% of
implanted tumors); the Ma melanotic and MI hypomelanotic
variants are characterized by slow growth rate, melanotic
(di¡erentiated) phenotype, and high metastatic potential
(90% of implanted tumors metastasize) (Bomirski et al, 1988).
Ab amelanotic melanoma also has a signi¢cantly higher rate
of anaerobic and aerobic glycolysis, and is more immunogenic
than Ma and MI melanomas (Scislowski et al, 1984). The two
melanotic melanomas (Ma and MI) di¡er in the type of melanin
produced, e.g., eumelanin in Ma and pheomelanin in MI
melanoma, and also in growth rate, which is slightly but
signi¢cantly slower in MI melanoma (Bomirski et al, 1988;
Slominski and Paus, 1993a).
Normal skin had signi¢cantly higher PLP (Table IV) and PL
kinase activity (TableV) than the melanomas. The slow growing
MI hypomelanotic melanoma had signi¢cantly less PMP than
normal skin and the more rapidly growing Ab and Ma
melanomas. Normal skin and the Ab melanoma had
signi¢cantly higher activity of PMP oxidase than the slower
growing Ma and MI melanomas (Table V). Ab melanoma had
higher PLP hydrolase activity than skin or the other melanomas.
The increased hydrolase activity could contribute to the higher,
more variable PL content of the Ab melanoma samples.
Figure1. Expression of the TNAP gene in rodent and human skin.
Northern blotting shows absence of TNAP mRNA expression in human
skin samples and HaCaT keratinocytes.
Figure 2. Histology of the skin in TNAP knockout mice (A, ^/^; B, ^/+)
in comparison to wild-type phenotype (C, +/+). Hematoxylin and eosin.
Microscopic magni¢cation: 33.
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In vitro metabolism of vitamin B-6 in cultured skin
cells Metabolism of vitamin B-6 was also evaluated in
homogenous cultured cell populations. Table VI shows the B-6
vitamer levels determined in cultured human melanoma cells
and keratinocytes. PLP levels in these cell lines were similar to
those in human skin whereas PMP was higher than in human
skin. PL concentrations in both the human and hamster cell
lines tended to be higher than in normal skin. Some of these
di¡erences may re£ect the higher vitamin B-6 content of the
DMEM in comparison to plasma. Nevertheless, the media used
to culture melanoma and HaCaT cells were free of PL and PLP;
only PN was present at concentrations of 4 mg per l and 0.2 mg
per l in DMEM and Ham’s F10 medium (Table I), respectively.
Thus, PLP was supplied only by serum (10% of FBS in the
culture medium). Therefore, changes in intracellular vitamer
concentrations most likely re£ect speci¢c metabolic properties of
the individual cell lines.
Activity of PL kinase, PMP oxidase, and PLP hydrolase was
measured in cultured epidermal keratinocytes and melanoma
cells (Table VII). There was considerable variation in the activity
of vitamin B-6 metabolizing enzymes between the cell lines.
Kinase activity was lowest in the WM 35 and WM 164
melanomas and highest in the immortalized human melanoma
cells. The human melanoma cells also had signi¢cantly higher
oxidase activity than normal skin and several cell lines. The
AbC1 cells had signi¢cantly higher oxidase activity than normal
hamster skin. Phosphatase activity exhibited a marked substrate
e¡ect. With PNP as the substrate activity was usually 3-fold
higher than when using PLP (Table VII). With either substrate
phosphatase activity was highest in the HaCaT keratinocytes at
15 times the activity in human skin. In contrast neonatal
keratinocytes had low phosphatase activity. Within melanoma
lines we did not ¢nd a direct relationship between biologic
behavior of the original tumor and enzymatic activity, e.g., PLP
hydrolase activity was lowest in the WM 35 and WM 164 lines
that derived from radial growth phase and metastatic
melanomas, but highest in WM 853 and WM 98 lines that
derived from metastatic and vertical growth phase melanomas,
respectively. This lack of correlation between melanoma
behavior and enzymatic activity extended to PL kinase and
Table IV. B-6 vitamers in hamster skin and Bomirski transplantable melanomas
PLP PMP PL Total
Sample n (nmol per g protein) (nmol per g protein) (nmol per g protein) (nmol per g protein)
Normal skin 2 5871a 4673a 1171 11572
Skin with nevus 2 34711a,b 2076b,c 1373 67720
Ab melanotic 3 2975b 3678a,c 46722 112734
Ma melanotic 5 2173b 3572a,c 1172 6777
MI hypomelanotic 4 1872b 1773b 771 4175
Mean7SEM. Values in the same column with di¡erent superscripts are signi¢cantly di¡erent (po0.05).
TableV. Activity of vitamin B-6 metabolizing enzymes in hamster skin and Bomirski transplantable melanomas
Kinase Oxidase PLPase
Sample (nmol per g protein per min) (nmol per g protein per min) (nmol per g protein per min) Kinase/oxidase PLPase/kinase
Normal skin (2) 2979a 1.970.6a 161715b 1570.1a,b 6.472.6a
Skin with nevus (2) 1374b 0.6570.05b 102726b 2177a,b 7.970.2a
Ab amelanotic 8.870.2 (3)b 1.8570.05 (2)a,c 9057170 (3)a 4.870.1 (2)a 103719 (3)b
Ma melanotic (5) 10.270.5b 0.9470.13b,c 84718b 1272a 8.472.0a
MI hypomelanotic (4) 8.471.0b 0.3870.06b 240787b 2473b 34716a
Mean7SEM.
Items in the same column with di¡erent superscripts are signi¢cantly di¡erent (po0.05).
TableVI. B-6 vitamer concentrations in human skin and selected melanoma lines and keratinocytes
PN HCl in medium PLP PMP PL Total
Sample (mg per l) (nmol per g protein) (nmol per g protein) (nmol per g protein) (nmol per g protein)
Human skin ^ 44713a (7) 772 (7)c 29714 (6) 78714 (6)
WM 35 melanoma (2) 4.0 30710 2979d 81714 139712
WM 164 melanoma (2) 4.0 4573 2976d 73710 14672
WM 98 melanoma (2) 4.0 6471 2473d 39713 126710
SK-MEL188 (1) 4.0 36 34d 180 250
SK-MEL188 (4) 0.2 48717 2873d 56712 132710
HaCaT keratinocytes (5) 4.0 3278c 2172d 50713 103715
Neonatal keratinocytes (3) 0.06 36716c 2972d 53722 118739
Hamster skin (2) ^ 5871 4673 1171c 11572
AbC1 (3) 4.0 ^b 1370.3 4779c,e ^
AbC1 (3) 0.2 ^ 44710 87712d,e ^
AbC1þ10^7 M a-MSH (2) 0.2 ^ 3175 92714d,e ^
AbC1þ10^7 M ACTH (2) 0.2 ^ 2974 12872d ^
aMean7SEM. Numbers in parentheses are number of samples. The statistical analysis compared cells derived from humans to human skin and the AbC1 cells from
hamster to hamster skin.
Values in the same column with di¡erent superscripts are signi¢cantly di¡erent (po0.05).
bAs these were small samples analyzed before adoption of the more sensitive chlorite detection reagent, PLP was not detected.
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PMP oxidase (see above). In hamster AbC-1 melanoma lines PLP
hydrolase activity was higher, at values similar to the parental Ab
amelanotic transplantable melanoma.Therefore, we conclude that
in cultured skin cells metabolism of vitamin B-6 appears to be
independent of growth rate, tumorigenicity, and level of cell
di¡erentiation.
As changes in media composition can induce cellular
di¡erentiation, we examined e¡ects of culture medium on the
activity of vitamin B-6 metabolizing enzymes. We used
amelanotic AbC-1 hamster and SK-MEL188 human melanomas
that can change their phenotype to melanotic when cultured in
DMEM (containing high L-tyrosine concentration) rather than
in F10 medium (low tyrosine) (Slominski et al, 1988; 1999a).
Analysis of experiments with both types of media and cells
demonstrated that the F10 medium with lower concentrations of
PN and other nutrients resulted in signi¢cantly higher activity of
PL kinase [2973 vs 1175 (mean7SEM), po0.004, two-way
ANOVA] and PMP oxidase [1371 vs 772 (mean7SEM),
po0.003, two-way ANOVA]. There was no di¡erence in PLP
hydrolase activity between amelanotic cells (cultured in F10
medium) and melanotic cells (cultured in DMEM). Moreover,
as adrenocorticotropin (ACTH) has been shown to stimulate
PLP hydrolase activity in the adrenals (Mahuren et al, 1999), we
tested the e¡ect of ACTH and of a-MSH [inducers of
melanoma cell di¡erentiation (Schallreuter et al, 1998)] on
enzyme activity. Culturing of AbC-1 melanoma cells in
the presence of a biologically e¡ective concentration of 10^7 M
a-MSH or ACTH for 48 h was without signi¢cant e¡ect on
kinase, oxidase, or phosphatase activity (Table VII). Thus, skin
metabolism of vitamin B-6 is predetermined by the cell type
and is also constitutive, at least in melanoma cells.
Testing for correlations from all samples that had complete
data on B-6 vitamers and enzymes (n¼ 54;Table VIII) showed,
as would be expected, that PLP, PMP, and PL were highly
correlated with the total vitamin B-6 content. PLP and PMP
were correlated with each other but not with PL. Similarly, PLP
and PMP but not PL were highly correlated with kinase and
oxidase activity. Total vitamin B-6 was also correlated with
kinase and oxidase activity. PLP hydrolase activity was
signi¢cantly correlated only with kinase activity.
DISCUSSION
Skin lesions were the ¢rst symptoms identi¢ed with vitamin B-6
de¢ciency in rats (Gy˛rgy, 1964) and seborrheic dermatitis was
subsequently observed in vitamin B-6 de¢ciency in humans
(Prasad et al, 1983). Vitamin B-6 de¢ciency may also impair im-
mune function (Doke et al, 1997), and PLP could be locally im-
portant as a cofactor in the decarboxylation reactions by which
skin produces biogenic amines such as catecholamines, histamine,
and serotonin (Slominski and Wortsman, 2000; Slominski et al,
2002).
Whereas interest in B-6 vitamers tends to focus on PLP, it is
notable that higher PMP content was the most consistent di¡er-
ence between cultured melanoma cells and normal human skin.
This was not associated with any consistent di¡erences in kinase
or oxidase activity. Alkaline phosphatase is an ectoenzyme essen-
tial for the hydrolysis of PLP in plasma prior to transport into
cells (Whyte et al, 1995). The marked elevation of plasma PLP in
hypophosphatasia (Whyte et al, 1985) clearly illustrates the role of
alkaline phosphatase in maintaining extracellular PLP concentra-
tions. Knockout mice missing TNAP die unless supplemented
with PL (Waymire et al, 1995), demonstrating that alkaline phos-
phatase also in£uences the intracellular environment. Autopsy
data from three infants with hypophosphatasia (Whyte et al,
1988) detected no changes in tissue concentrations of vitamin B-
6. Nevertheless, PLP concentrations in liver, brain, heart, kidney,
and skeletal muscle of the knockout mice were reduced approxi-
mately 40% (Waymire et al, 1995). Based on data from rat hepato-
cytes, Li et al (1974) concluded that protein binding and hydrolysis
of excess, unbound PLP by alkaline phosphatase controlled the
hepatic concentrations of PLP. A regulatory role for alkaline
phosphatase is also supported by variations in phosphatase activ-
ity in rat brain during development (Bishayee and Bachhawat,
1972) and by the 200-fold excess activity of PLP hydrolase
compared to PL kinase activity in rat pineal gland (Ebadi and
Govitrapong, 1979). The PLP hydrolase activity in human liver
was 25-fold higher than PL kinase activity (Merrill et al, 1984),
similar to our results in human skin. In the cultured cells,
however, the ratio varied widely with no signi¢cant correlation
between PLPase and intracellular vitamer concentrations. For ex-
ample, PLP concentrations in the HaCaT keratinocytes were simi-
lar to those in other cell lines even though the PLPase activity
was signi¢cantly higher. Therefore, in these cell lines PLP hydro-
lase does not appear to be the primary regulator of intracellular
PLP concentrations. Furthermore, the intriguing observation that
mRNA for TNAP was not detected in human skin, HaCaT ker-
atinocytes, or neonatal keratinocytes raises the possibility that
TNAP is not the primary PLP hydrolase in human epidermis.
PLP hydrolase activity has been reported in enzymes other than
alkaline phosphatase. Fonda and Zhang (1995) isolated a soluble
PLP hydrolase with a pH optimum of 7.4 from human erythro-
cytes, and an acid phosphatase with PLP hydrolase activity was
isolated from the nuclear fraction of mouse liver (Kyaw, 1980).
It should be noted that PLP readily forms Schi¡ bases with
amines including lysine residues in proteins and the amino
groups of common bu¡ers including Tris (Davis et al, 1982).
Unpublished data from our laboratory indicated that PLP or
PNP hydrolase activity with a Tris bu¡er was higher than with
2-amino-2-methyl-1-propanol or triethanolamine bu¡ers.
Therefore, we continue to use Tris. In order to minimize pro-
blems with nonspeci¢c binding of the aldehyde group to proteins
or other amines, however, we favor PNP as the routine substrate
for hydrolase assays. The binding of PLP toTris could contribute
to the lower hydrolase activity of PLP compared to PNP
(TableVII).
Whereas signi¢cant PL kinase activity is found in essentially
all mammalian organs, the presence of PMP oxidase activity is
less consistent (Fonda, 1988). Fonda reported that PMP oxidase
activity in liver was 15-fold higher than in muscle in mice and
6-fold higher in rats. Our observed activity of approximately 37
nmol per g protein per min for mouse liver compares well with
the values of 50^125 nmol per g protein per min reported by
Fonda using a di¡erent assay. As oxidase activity in mouse skin
was one-third of liver activity, vitamin B-6 metabolism may
be more active in skin than in muscle. Avariety of neoplastic cells
of neural and hepatic origin showed little PMP oxidase activity
and, because fetal tissues from the same sources were also
low in oxidase activity, it was concluded that the oxidase was
developmentally regulated with the neoplastic tissues showing fe-
tal characteristics (Ngo et al, 1998). In contrast, oxidase activity in
TableVIII. Correlations between vitamin B-6 metabolizing
enzymes and B-6 vitamers (n¼ 54)
PMP PL Total Kinase Oxidase PLPase
PLP r 0.491 0.0458 0.706 0.491 0.457 ^0.0933
p 0.000161 0.742 2.44E-09 0.000165 0.00052 0.502
PMP r ^0.0578 0.705 0.543 0.662 0.179
p 0.678 2.76E-09 2.18E-05 4.89E-08 0.196
PL r 0.568 0.0336 0.245 ^0.0107
p 7.38E-06 0.809 0.0737 0.939
Total r 0.514 0.686 0.0501
p 7.02E-05 1.04E-08 0.719
Kinase r 0.326 0.284
p 0.0163 0.0374
Oxidase r ^0.0356
p 0.798
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neonatal keratinocytes and the various melanoma cell lines used
in this work (Table VII) was comparable to the activity in
normal human skin.
In the C57BL/6 mouse skin physiology and morphology
change dramatically during hair growth (Slominski and Paus,
1993b) with increases in melanogenesis and endocrine and im-
mune activity in the anagen stage.These are low or absent during
the resting telogen and involution catagen stages (Slominski et al,
1991; 1994; Slominski and Paus, 1993b). Histochemical correlation
studies performed by Handjiski et al (1994) showed hair cycle and
compartment-dependent changes in alkaline phosphatase activity.
Thus, enzyme activity in outer root sheath keratinocytes was
present only during late anagen and catagen, whereas in sebac-
eous glands the highest activity was found during catagen and
telogen; in dermal papilla the same activity was present through-
out the entire hair cycle (Handjiski et al, 1994). Accordingly,
the present changes in biochemically detected enzyme activity
obtained in homogenates of full thickness skin correspond to
those previously seen in keratinocytes of the outer root sheath
follicle. We suggest that this increase in phosphatase activity
would provide dephosphorylated vitamers for transport into the
follicular structures to meet the requirements for increased cellu-
lar metabolism during formation of the hair shaft.
DiSorbo et al (1985) reported that the growth of B16 melanoma
in vitrowas inhibited by 5 mM PN or 0.5 mM PL, concentrations
of PN much higher than the 0.02 mM used in these studies.
In vivo treatment of mice with 0.5 g PL per kg body weight re-
duced the growth of both new and established B16 melanomas
(DiSorbo et al, 1985). This dosage greatly exceeds the recom-
mended safe upper limit of 100 mg for humans (Standing Com-
mittee on the Scienti¢c Evaluation of Dietary Reference Intakes,
1998) and would almost certainly be toxic. Topical administration
of PL, however, exhibited selective direct toxicity for melanoma
resulting in 50% necrosis and regression (Nathanson et al, 1983).
Topical application was also e¡ective in mice with murine B16-
C3 melanomas (Maksymowych et al, 1993).Whereas these studies
focused on interference with the steroid receptors as the possible
mechanism, more recent studies have demonstrated that PL
also inhibits the growth of breast cancer cells, which are estrogen
receptor negative (Davis and Cowing, 2000).
Concluding remarks The vitamin B-6 content of skin was
approximately 100 nmol per g protein. PMP concentration was
similar to PLP in mouse and hamster but was only 15% of the
PLP concentration in human skin. The activity of PMP oxidase
and PLP hydrolase tended to increase during the anagen IV and
VI phases of the hair cycle in mouse skin and was signi¢cantly
increased in the rapidly growing melanomas compared to either
normal skin or slower growing tumors. Reducing the content of
PN and other nutrients in the cell culture medium signi¢cantly
increased the activity of PL kinase and PMP oxidase. Although in
other tissues alkaline phosphatase has been proposed as a
regulatory enzyme for vitamin B-6 metabolism, in this study
B-6 vitamer content of skin and cultured cells was signi¢cantly
correlated with kinase and oxidase but not phosphatase activity.
Most unexpected were the observations made in the TNAP
knockout mice that showed a surprising absence of pathologic
changes in the skin and adnexal structures. These observations
together with the absence of detectable TNAP mRNA in
human immortalized keratinocytes (HaCaT) and human skin,
both of which exhibit signi¢cant PLP hydrolase activity, suggest
that skin PLP hydrolase activity may be associated with an
enzyme other thanTNAP.
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